Amlodipine

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Amlodipine besilate 6.93mg equivalent to 5 mg amlodipine

Disponibbli minn:

Multichem NZ Limited

INN (Isem Internazzjonali):

Amlodipine besilate 6.93 mg (equivalent to 5 mg amlodipine)

Dożaġġ:

5 mg

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Active: Amlodipine besilate 6.93mg equivalent to 5 mg amlodipine Excipient: Colloidal silicon dioxide Magnesium stearate Mannitol Microcrystalline cellulose Sodium starch glycolate

Unitajiet fil-pakkett:

Blister pack, PVC/PVdC-PVC/PVdC/aluminium in a acrdboard carton, 100 tablets

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Cadila Pharmaceuticals Ltd

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, PVC/PVdC-PVC/PVdC/aluminium in a acrdboard carton - 100 tablets - 36 months from date of manufacture stored at or below 30°C

Data ta 'l-awtorizzazzjoni:

2010-11-22

Karatteristiċi tal-prodott

1
NEW ZEALAND DATA SHEET
1 PRODUCT NAME
Vasorex
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Amlodipine besilate 2.5 mg, 5 mg and 10 mg tablets
3 PHARMACEUTICAL FORM
Vasorex 2.5 mg tablets are white to off white, round with “C”
debossed on one side and
“126” on the other side. Alternatively, they are debossed on one
side with “3235” and
“WPI” on the other side. Each tablet contains amlodipine besilate
equivalent to 2.5 mg of
amlodipine.
Vasorex 5 mg tablets are white to off white, round with “C”
debossed on one side and
“127” on the other side. Alternatively, they are debossed on one
side with “3236” and
“WPI” on the other side. Each tablet contains amlodipine besilate
equivalent to 5 mg
amlodipine.
Vasorex 10 mg tablets are white to off white, round with “C”
debossed on one side and
“128” on the other side. Alternatively, they are debossed on one
side with “3237” and
“WPI” on the other side. Each tablet contains amlodipine besilate
equivalent to 10 mg
amlodipine.
Do not halve the tablet as dose equivalence when the tablet is divided
has not been
established.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
Vasorex is indicated for the first line treatment of hypertension and
can be used as the
sole agent to control blood pressure in the majority of patients.
Patients not adequately
controlled on a single antihypertensive agent may benefit from the
addition of amlodipine,
which has been used in combination with a thiazide diuretic, beta
adrenoceptor blocking
agent, or an angiotensin-converting enzyme inhibitor.
Vasorex is indicated for the first line treatment of myocardial
ischaemia, whether due to
fixed obstruction (stable angina) and/or vasospasm/vasoconstriction
(Prinzmetal's or
variant angina) of coronary vasculature.
Vasorex
may
be
used
where
the
clinical
presentation
suggests
a
possible
vasospastic/vasoconstrictive component but where
vasospasm/vasoconstriction has not
been confirmed. Vasorex may be used alone as monotherapy, or in
combination with other
anti